Reading Time: 7 minutesOn 25th April 2023 Tofersen (now known as Qalsody in the US), a treatment for SOD1 MND was approved by the Food and Drug Administration
Tag: FDA approval
Reading Time: 5 minutesLast year was a really exciting year for MND clinical trials, with more trials recruiting in the UK than ever before, some promising results being